Telix Pharmaceuticals Ltd
ASX:TLX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
AU |
|
Laramide Resources Ltd
TSX:LAM
|
CA |
|
Astrakhanskaya Energosbytovaya Kompaniya PAO
MOEX:ASSB
|
RU |
|
CPT Global Ltd
ASX:CGO
|
AU |
|
American Water Works Company Inc
NYSE:AWK
|
US |
|
Grupo Aeroportuario del Centro Norte SAB de CV
BMV:OMAB
|
MX |
|
E
|
Eviso SpA
MIL:EVS
|
IT |
|
GenusPlus Group Ltd
ASX:GNP
|
AU |
|
S
|
Streamwide SA
F:07R
|
FR |
|
F
|
Fade Gida Yatirim Sanayi Ticaret AS
IST:FADE.E
|
TR |
|
C
|
Cox Abg Group SA
MAD:COXG
|
ES |
|
B
|
Belon OAO
MOEX:BLNG
|
RU |
Wall Street
Price Targets
TLX Price Targets Summary
Telix Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for
TLX
is 24.1 AUD
with a low forecast of 17.17 AUD and a high forecast of 33.6 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TLX's stock price target?
Price Target
24.1
AUD
According to Wall Street analysts, the average 1-year price target for
TLX
is 24.1 AUD
with a low forecast of 17.17 AUD and a high forecast of 33.6 AUD.
What is Telix Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
17%
For the last 7 years the
compound annual growth rate for
Telix Pharmaceuticals Ltd's revenue is
228%.
The projected
CAGR
for the next 3 years is
17%.
What is Telix Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
71%
The
compound annual growth rate
of Telix Pharmaceuticals Ltd's operating income for the next 3 years is
71%.
